Late-Breaking Presentation on the Phase 3 LEAP-002 Study Investigating the Lenvatinib plus Pembrolizumab Combination Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma
Eisai Co., Ltd.
Source: pressreleasepoint.com
Stay updated with breaking news from Petera Kaufman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.